Scientific Publications

Advancing dermatological science.

May 2021

EADV Spring Symposium 2021

Roflumilast Cream, Safety and Efficacy in two Ph3 Studies (DERMIS-1 and DERMIS-2) in Patients with Chronic Plaque Psoriasis

April 2021

AAD 2021

Roflumilast Cream, Correlation of Itch and Disease Severity in Adults with Chronic Plaque Psoriasis, Ph2b Study

April 2021

AAD 2021

Roflumilast Foam, Safety and Efficacy in Patients with Scalp and Body Psoriasis, Ph2b Study

April 2021

AAD 2021

Roflumilast Foam, Safety and Efficacy in Patients with Seborrheic Dermatitis, Ph2 Study

April 2021

AAD 2021

Roflumilast Cream, Safety and Efficacy in Steroid-sensitive Areas in Adults with Chronic Plaque Psoriasis, Ph2b Study

April 2021

AAD 2021

PASI-HD Improved Precision in Measuring Disease Severity in Patients with Mild to Moderate Plaque Psoriasis Treated with Roflumilast Cream, Ph2b Study

March 2021

Innovations in Dermatology 2021

Roflumilast Cream, Long-term Safety and Efficacy in a Ph2b Study in Adults with Chronic Plaque Psoriasis

October 2020

EADV, Fall Clinical, SDPA 2020

Roflumilast Cream, Improved Patient Burden of Signs and Symptoms in Adults with Chronic Plaque Psoriasis, Ph2b study

October 2020

EADV, Fall Clinical, SDPA 2020

Roflumilast Cream, Improved Itch Severity and Itch-related Sleep Loss in Adults with Chronic Plaque Psoriasis, Ph2b study

October 2020

EADV, Fall Clinical, SDPA 2020

Roflumilast Cream, Safety and Efficacy in a Ph2 Proof-of-Concept study in Adults with Atopic Dermatitis

August 2020

J Drugs Dermatol

Roflumilast cream improves signs & symptoms of plaque psoriasis (phase 1/2a randomized, controlled)

August 2020

Journal of Drugs in Dermatology

Roflumilast Cream, Results of Phase 1/2a Study

Meaningful innovation at a glance.

Download our corporate fact sheet.

Download